Literature DB >> 29303444

Reductions in brain pericytes are associated with arteriovenous malformation vascular instability.

Ethan A Winkler1,2, Harjus Birk1, Jan-Karl Burkhardt1, Xiaolin Chen2,3, John K Yue1, Diana Guo2, W Caleb Rutledge1,2, George F Lasker1, Carlene Partow1, Tarik Tihan4, Edward F Chang1, Hua Su2, Helen Kim2, Brian P Walcott1,2,5, Michael T Lawton1,2.   

Abstract

OBJECTIVEBrain arteriovenous malformations (bAVMs) are rupture-prone tangles of blood vessels with direct shunting of blood flow between arterial and venous circulations. The molecular and/or cellular mechanisms contributing to bAVM pathogenesis and/or destabilization in sporadic lesions have remained elusive. Initial insights into AVM formation have been gained through models of genetic AVM syndromes. And while many studies have focused on endothelial cells, the contributions of other vascular cell types have yet to be systematically studied. Pericytes are multifunctional mural cells that regulate brain angiogenesis, blood-brain barrier integrity, and vascular stability. Here, the authors analyze the abundance of brain pericytes and their association with vascular changes in sporadic human AVMs.METHODSTissues from bAVMs and from temporal lobe specimens from patients with medically intractable epilepsy (nonvascular lesion controls [NVLCs]) were resected. Immunofluorescent staining with confocal microscopy was performed to quantify pericytes (platelet-derived growth factor receptor-beta [PDGFRβ] and aminopeptidase N [CD13]) and extravascular hemoglobin. Iron-positive hemosiderin deposits were quantified with Prussian blue staining. Syngo iFlow post-image processing was used to measure nidal blood flow on preintervention angiograms.RESULTSQuantitative immunofluorescent analysis demonstrated a 68% reduction in the vascular pericyte number in bAVMs compared with the number in NVLCs (p < 0.01). Additional analysis demonstrated 52% and 50% reductions in the vascular surface area covered by CD13- and PDGFRβ-positive pericyte cell processes, respectively, in bAVMs (p < 0.01). Reductions in pericyte coverage were statistically significantly greater in bAVMs with prior rupture (p < 0.05). Unruptured bAVMs had increased microhemorrhage, as evidenced by a 15.5-fold increase in extravascular hemoglobin compared with levels in NVLCs (p < 0.01). Within unruptured bAVM specimens, extravascular hemoglobin correlated negatively with pericyte coverage (CD13: r = -0.93, p < 0.01; PDGFRβ: r = -0.87, p < 0.01). A similar negative correlation was observed with pericyte coverage and Prussian blue-positive hemosiderin deposits (CD13: r = -0.90, p < 0.01; PDGFRβ: r = -0.86, p < 0.01). Pericyte coverage positively correlated with the mean transit time of blood flow or the time that circulating blood spends within the bAVM nidus (CD13: r = 0.60, p < 0.05; PDGFRβ: r = 0.63, p < 0.05). A greater reduction in pericyte coverage is therefore associated with a reduced mean transit time or faster rate of blood flow through the bAVM nidus. No correlations were observed with time to peak flow within feeding arteries or draining veins.CONCLUSIONSBrain pericyte number and coverage are reduced in sporadic bAVMs and are lowest in cases with prior rupture. In unruptured bAVMs, pericyte reductions correlate with the severity of microhemorrhage. A loss of pericytes also correlates with a faster rate of blood flow through the bAVM nidus. This suggests that pericytes are associated with and may contribute to vascular fragility and hemodynamic changes in bAVMs. Future studies in animal models are needed to better characterize the role of pericytes in AVM pathogenesis.

Entities:  

Keywords:  BBB = blood-brain barrier; CD13 = aminopeptidase N; CD31 = platelet endothelial adhesion molecule 1; GFAP = glial fibrillary acidic protein; MTT = mean transit time; NVLC = nonvascular lesion control; PDGFRβ = platelet-derived growth factor receptor–beta; ROI = region of interest; arteriovenous malformations; bAVM = brain arteriovenous malformation; blood-brain barrier; intracerebral hemorrhage; microhemorrhage; pericytes; stroke; vascular disorders

Mesh:

Substances:

Year:  2018        PMID: 29303444      PMCID: PMC6033689          DOI: 10.3171/2017.6.JNS17860

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  44 in total

1.  Pericytes regulate the blood-brain barrier.

Authors:  Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

2.  Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery.

Authors:  Muge Yemisci; Yasemin Gursoy-Ozdemir; Atay Vural; Alp Can; Kamil Topalkara; Turgay Dalkara
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

Review 3.  Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.

Authors:  Rui Zhang; Wan Zhu; Hua Su
Journal:  Acta Neurochir Suppl       Date:  2016

4.  Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch.

Authors:  Fangfei Li; Yu Lan; Youliang Wang; Jun Wang; Guan Yang; Fanwei Meng; Hua Han; Anming Meng; Yaping Wang; Xiao Yang
Journal:  Dev Cell       Date:  2011-03-15       Impact factor: 12.270

5.  Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.

Authors:  Wanqiu Chen; Yi Guo; Espen J Walker; Fanxia Shen; Kristine Jun; S Paul Oh; Vincent Degos; Michael T Lawton; Tarik Tihan; Dimitrios Davalos; Katerina Akassoglou; Jeffrey Nelson; John Pile-Spellman; Hua Su; William L Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

Review 6.  The blood-brain barrier: an overview: structure, regulation, and clinical implications.

Authors:  Praveen Ballabh; Alex Braun; Maiken Nedergaard
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

7.  Capillary pericytes regulate cerebral blood flow in health and disease.

Authors:  Catherine N Hall; Clare Reynell; Bodil Gesslein; Nicola B Hamilton; Anusha Mishra; Brad A Sutherland; Fergus M O'Farrell; Alastair M Buchan; Martin Lauritzen; David Attwell
Journal:  Nature       Date:  2014-03-26       Impact factor: 49.962

8.  Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis.

Authors:  M Hellström; H Gerhardt; M Kalén; X Li; U Eriksson; H Wolburg; C Betsholtz
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

9.  Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain.

Authors:  Kassandra Kisler; Amy R Nelson; Sanket V Rege; Anita Ramanathan; Yaoming Wang; Ashim Ahuja; Divna Lazic; Philbert S Tsai; Zhen Zhao; Yi Zhou; David A Boas; Sava Sakadžić; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2017-01-30       Impact factor: 24.884

10.  Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.

Authors:  Ethan A Winkler; Jesse D Sengillo; John S Sullivan; Jenny S Henkel; Stanley H Appel; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2012-09-01       Impact factor: 17.088

View more
  33 in total

Review 1.  The pericyte microenvironment during vascular development.

Authors:  Laura B Payne; Huaning Zhao; Carissa C James; Jordan Darden; David McGuire; Sarah Taylor; James W Smyth; John C Chappell
Journal:  Microcirculation       Date:  2019-05-27       Impact factor: 2.628

Review 2.  Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications.

Authors:  Takahiro Ota; Masaki Komiyama
Journal:  Interv Neuroradiol       Date:  2020-02-05       Impact factor: 1.610

3.  Pericyte Progenitor Coupling to the Emerging Endothelium During Vasculogenesis via Connexin 43.

Authors:  Laura Beth Payne; Bhanu P Tewari; Logan Dunkenberger; Samantha Bond; Alyssa Savelli; Jordan Darden; Huaning Zhao; Caroline Willi; Ronak Kanodia; Rosalie Gude; Michael D Powell; Kenneth J Oestreich; Harald Sontheimer; Sophie Dal-Pra; John C Chappell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-10       Impact factor: 8.311

Review 4.  Molecular and genetic mechanisms in brain arteriovenous malformations: new insights and future perspectives.

Authors:  Sandra Vetiska; Thomas Wälchli; Ivan Radovanovic; Moncef Berhouma
Journal:  Neurosurg Rev       Date:  2022-10-11       Impact factor: 2.800

Review 5.  Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome.

Authors:  Joseph R Geraghty; Joseph L Davis; Fernando D Testai
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

Review 6.  Blood-Brain Barrier Mechanisms in Stroke and Trauma.

Authors:  Wenlu Li; Fang Cao; Hajime Takase; Ken Arai; Eng H Lo; Josephine Lok
Journal:  Handb Exp Pharmacol       Date:  2022

Review 7.  Traumatic Brain Injury: Ultrastructural Features in Neuronal Ferroptosis, Glial Cell Activation and Polarization, and Blood-Brain Barrier Breakdown.

Authors:  Delong Qin; Junmin Wang; Anh Le; Tom J Wang; Xuemei Chen; Jian Wang
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

Review 8.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

9.  Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation.

Authors:  Rachel Muster; Nerissa Ko; Wade Smith; Hua Su; Melissa A Dickey; Jeffrey Nelson; Charles E McCulloch; Patricia K Sneed; Jennifer L Clarke; David A Saloner; Laura Eisenmenger; Helen Kim; Daniel L Cooke
Journal:  BMJ Neurol Open       Date:  2021-03-17

Review 10.  Review of treatment and therapeutic targets in brain arteriovenous malformation.

Authors:  Peipei Pan; Shantel Weinsheimer; Daniel Cooke; Ethan Winkler; Adib Abla; Helen Kim; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.